These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29029672)

  • 1. Emotion Regulation Protects Against Recurrence of Depressive Symptoms Following Inpatient Care for Major Depressive Disorder.
    Ebert DD; Hopfinger L; Bockting CLH; Berking M
    Behav Ther; 2017 Nov; 48(6):739-749. PubMed ID: 29029672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful emotion regulation skills application predicts subsequent reduction of symptom severity during treatment of major depressive disorder.
    Radkovsky A; McArdle JJ; Bockting CL; Berking M
    J Consult Clin Psychol; 2014 Apr; 82(2):248-62. PubMed ID: 24564219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a text-message-based maintenance intervention for Major Depressive Disorder after inpatient cognitive behavioral therapy.
    Schlicker S; Ebert DD; Middendorf T; Titzler I; Berking M
    J Affect Disord; 2018 Feb; 227():305-312. PubMed ID: 29132073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing symptoms of major depressive disorder through a systematic training of general emotion regulation skills: protocol of a randomized controlled trial.
    Ehret AM; Kowalsky J; Rief W; Hiller W; Berking M
    BMC Psychiatry; 2014 Jan; 14():20. PubMed ID: 24467807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative affect as mediator between emotion regulation and medically unexplained symptoms.
    Schwarz J; Rief W; Radkovsky A; Berking M; Kleinstäuber M
    J Psychosom Res; 2017 Oct; 101():114-121. PubMed ID: 28867416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    J Affect Disord; 2016 Jul; 199():148-56. PubMed ID: 27104803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice of therapy acquired regulatory skills and depressive relapse/recurrence prophylaxis following cognitive therapy or mindfulness based cognitive therapy.
    Segal ZV; Anderson AK; Gulamani T; Dinh Williams LA; Desormeau P; Ferguson A; Walsh K; Farb NAS
    J Consult Clin Psychol; 2019 Feb; 87(2):161-170. PubMed ID: 30431297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased suppression of negative and positive emotions in major depression.
    Beblo T; Fernando S; Klocke S; Griepenstroh J; Aschenbrenner S; Driessen M
    J Affect Disord; 2012 Dec; 141(2-3):474-9. PubMed ID: 22483953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotion regulation skills training enhances the efficacy of inpatient cognitive behavioral therapy for major depressive disorder: a randomized controlled trial.
    Berking M; Ebert D; Cuijpers P; Hofmann SG
    Psychother Psychosom; 2013; 82(4):234-45. PubMed ID: 23712210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful application of adaptive emotion regulation skills predicts the subsequent reduction of depressive symptom severity but neither the reduction of anxiety nor the reduction of general distress during the treatment of major depressive disorder.
    Wirtz CM; Radkovsky A; Ebert DD; Berking M
    PLoS One; 2014; 9(10):e108288. PubMed ID: 25330159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive emotion regulation strategies in outpatients with major depressive disorder.
    Lei H; Zhang X; Cai L; Wang Y; Bai M; Zhu X
    Psychiatry Res; 2014 Aug; 218(1-2):87-92. PubMed ID: 24774074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    Psychotherapy (Chic); 2015 Jun; 52(2):268-77. PubMed ID: 25985046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rumination-focused cognitive behaviour therapy vs. cognitive behaviour therapy for depression: study protocol for a randomised controlled superiority trial.
    Hvenegaard M; Watkins ER; Poulsen S; Rosenberg NK; Gondan M; Grafton B; Austin SF; Howard H; Moeller SB
    Trials; 2015 Aug; 16():344. PubMed ID: 26260780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and implementation of emotion regulation strategies in major depressive disorder: An integrative review.
    Liu DY; Thompson RJ
    Clin Psychol Rev; 2017 Nov; 57():183-194. PubMed ID: 28739277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Anna Clark L; Thase ME; Jarrett RB
    Psychiatry Res; 2017 Jul; 253():174-181. PubMed ID: 28388454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive working mechanisms of the prevention of relapse in remitted recurrent depression (NEWPRIDE): protocol of a randomized controlled neuroimaging trial of preventive cognitive therapy.
    van Kleef RS; Bockting CLH; van Valen E; Aleman A; Marsman JC; van Tol MJ
    BMC Psychiatry; 2019 Dec; 19(1):409. PubMed ID: 31856771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial.
    Bockting CL; Smid NH; Koeter MW; Spinhoven P; Beck AT; Schene AH
    J Affect Disord; 2015 Oct; 185():188-94. PubMed ID: 26188380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    Behav Ther; 2019 Jul; 50(4):765-777. PubMed ID: 31208686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.
    Bockting CL; Hollon SD; Jarrett RB; Kuyken W; Dobson K
    Clin Psychol Rev; 2015 Nov; 41():16-26. PubMed ID: 25754289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.